Clinical Studies Sponsored by Sirnaomics | 11 results

Safety, Tolerability, PK, Anti-Tumor Activity of STP705 Injected IT in Cholangiocarcinoma, Hepatocellular Carcinoma or Liver Metastases in Subjects With Advanced/Metastatic or Surgically Unresectable Solid Tumors Who Are Refractory to Standard Therapy

Name	NCT Number	Health Conditions in Trial	Clinical Trial Start Date	Study Completion Date	Clinical Trial Study Type
‌ Single Ascending Dose of FXI-GalNAc-siRNA in Healthy Subjects	NCT05844293	‌ FXI	May 16, 2023	2024	Interventional
‌ Open Label, Dose Escalation Study for the Safety and Efficacy of STP705 in Adult Patients With Basal Cell Carcinoma	NCT04669808		December 28, 2020	July 30, 2023	Interventional
‌ Study to Evaluate Safety, Efficacy of Intralesional Injection of STP705 in Adults With Facial isSCC	NCT05421013		August 1, 2022	2023	Interventional
‌ Open Label, Dose Escalation Study for the Safety and Efficacy of STP705 in Adult Patients With isSCC	NCT04293679	Bowen's disease	March 21, 2019	October 21, 2020	Interventional
‌ A Study of STP707 Administered by IV in Healthy Subjects	NCT05309915		February 28, 2022	2023	Interventional
‌ Safety, Tolerability, Pharmacokinetics, Immunogenicity and Efficacy of STP705 in Adult Patients With Hypertrophic Scars	NCT05196373	Hypertrophic scar	2023	2024	Interventional
‌ Safety, Tolerability, PK, Anti-Tumor Activity of STP705 Injected IT in Cholangiocarcinoma, Hepatocellular Carcinoma or Liver Metastases in Subjects With Advanced/Metastatic or Surgically Unresectable Solid Tumors Who Are Refractory to Standard Therapy	NCT04676633	Hepatocellular carcinoma Cholangiocarcinoma	March 1, 2021	May 31, 2024	Interventional
‌ A Study to Evaluate Safety, Efficacy of Intralesional Injection of STP705 in Patients With isSCC	NCT04844983		May 18, 2021	2023	Interventional
‌ Ph. 1, Evaluation of Safety, Tolerability, PK, Anti-tumor Activity of STP707 IV in Subjects With Solid Tumors	NCT05037149		November 1, 2021	2024	Interventional
‌ A Study to Evaluate Safety, Tolerability of Subcutaneous Injection in Adult Subjects Undergoing Abdominoplasty	NCT05422378	Abdominal obesity	August 1, 2022	2023	Interventional
‌ A Randomized Study to Evaluate the Safety and Efficacy of Various Doses of STP705 in Subjects With Hypertrophic Scar	NCT02956317	Hypertrophic scar	2017	2018	Interventional